Skip to main content

Sotalol (International)

In the US, Sotalol (sotalol systemic) is a member of the following drug classes: group III antiarrhythmics, non-cardioselective beta blockers and is used to treat Atrial Fibrillation, Atrial Flutter and Ventricular Arrhythmia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AA07

CAS registry number (Chemical Abstracts Service)

0003930-20-9

Chemical Formula

C12-H20-N2-O3-S

Molecular Weight

272

Therapeutic Categories

β-adrenoceptor antagonist (beta blocker), non-cardioselective

Antiarrhythmic agent, class II and III

Chemical Name

Metanesulfonamide, N-[4-[1-hydroxy-2-[(1-metyletyl)amino]etyl]phenyl]-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.